Dyne Therapeutics, Inc. Common Stock

DYN US26818M1080

💰
Capitalization
Mid-cap

Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.

🔗
Website
https://www.dyne-tx.com
Annual Performance 1
2021 2022 2023 2024 2025
-37% -6% 14% 80% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
260
🙍
Insiders
12
Person Price Shares Total Published Completed
Cox John
CEO 		13.41
USD 		2,640
Sold 		35,402
USD 		05/09/2025 05/09/2025
Kerr Douglas
CMO 		13.41
USD 		873
Sold 		11,707
USD 		04/09/2025 05/09/2025
Friedl-naderer Johanna
CCO 		13.41
USD 		144
Sold 		1,931
USD 		04/09/2025 05/09/2025
Kerr Douglas
CMO 		13.27
USD 		3,552
Sold 		47,135
USD 		04/09/2025 04/09/2025
Friedl-naderer Johanna
CCO 		13.27
USD 		894
Sold 		11,863
USD 		04/09/2025 04/09/2025
Cox John
CEO 		9.11
USD 		100,000
Bought 		911,000
USD 		14/07/2025 14/07/2025
Kerr Douglas
CMO 		13.35
USD 		1,342
Sold 		17,916
USD 		05/06/2025 05/06/2025
Kerr Douglas
CMO 		13.35
USD 		1,342
Sold 		17,916
USD 		05/06/2025 05/06/2025
Friedl-naderer Johanna
CCO 		13.35
USD 		146
Sold 		1,949
USD 		05/06/2025 05/06/2025
Friedl-naderer Johanna
CCO 		13.35
USD 		146
Sold 		1,949
USD 		05/06/2025 05/06/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Dyne Therapeutics, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
-32% -46% -12% 100% 0% 0% -1%
Last 52W Low 52W High All-Time Low All-Time High β
12.65 6.81 35.40 4.36 47.04
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Kersten Dirk 73 128,401,355.72 1,758,922.68 09/01/2024 09/12/2024
Rhodes Jason P 35 44,258,206.57 1,264,520.19 15/02/2024 14/11/2024
Brumm Joshua T 18 19,370,394.14 1,076,133.01 11/12/2023 11/03/2024
Scalzo Richard William 30 7,993,711.29 266,457.04 04/12/2023 11/03/2025
High Susanna Gatti 21 6,921,762.73 329,607.75 02/11/2023 18/09/2024
Mcneill Jonathan 22 5,026,814.77 228,491.58 11/12/2023 19/08/2024
Beskrovnaya Oxana 22 3,395,220.93 154,328.22 11/12/2023 11/03/2025
Cox John 12 2,105,861.03 175,488.42 04/09/2024 05/09/2025
Farwell Wildon 16 972,719.74 60,794.98 11/12/2023 19/08/2024
Incerti Carlo 1 474,045.00 474,045.00 18/11/2024 18/11/2024
Kerr Douglas 5 110,561.06 22,112.21 05/03/2025 05/09/2025
Friedl-naderer Johanna 5 19,425.78 3,885.16 13/03/2025 05/09/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.